
Mount Sinai launches AI drug discovery centre
The Icahn School of Medicine at Mount Sinai has launched the AI Small Molecule Drug Discovery Center, with the aim of harnessing artificial intelligence (AI) to revolutionise drug development. The new Center will integrate AI with traditional drug discovery methods to identify and design new small-molecule therapeutics… Read More








